Work

P-052 Efficacy and Safety of ide-cel with Lenalidomide (R) Maintenance Versus R Maintenance Alone in Adult Patients (pts) with NDMM Who Have Suboptimal Response to ASCT: Phase 3 KarMMa-9 Trial

Year: 2024

Type: conference-abstract

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(24)01955-4

Authors: María-Victoria Mateos Manteca, Adam Cohen, Simon Harrison, Shaji Kumar, Aurore Perrot, Fredrik Schjesvold, Hermann Einsele, Paula Rodríguez-Otero, Ingerid Weum Abrahamsen, Carlos Fernández de Larrea, Rik Schots, Anna Truppel-Hartmann, Shafqat Inam, Fan Wu, Xiaobo Zhong, Thomas Finocchio, Mihaela Popa McKiver, Mark Cook, Noopur Raje

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4402735847

Cites:

Cited by:

Related to: 10